Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
For people with Type 2 Diabetes:
- People who have been diagnosed with Type 2 diabetes for at least 1 year
- People whose blood sugar control measurement (HbA1c) was 6.5% or higher before the study start date
- People who started semaglutide or another blood sugar-lowering medication before January 1st, 2023
- People who have been seen by a specialist diabetes doctor (endocrinologist) within the last 18 months
- People who have at least one blood sugar control measurement (HbA1c) taken within roughly 6 months before the study start date
- People who have given consent for their medical record data to be used for research
For people with Obesity (without Type 2 Diabetes):
- People who are 18 years of age or older
- People with a BMI of 27 or higher
- People whose blood sugar control measurement (HbA1c) was below 6.5% before the study start date
- People who started semaglutide before January 1st, 2023
- People who have been seen by a specialist diabetes doctor (endocrinologist) within the last 18 months
- People who have at least one blood sugar control measurement (HbA1c) taken within roughly 6 months before the study start date
- People who have given consent for their medical record data to be used for research
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have been diagnosed with Type 1 diabetes or a related condition called latent autoimmune diabetes in adults (LADA)
- People with a Type 2 diabetes diagnosis (this applies to the obesity group only)
- People who were pregnant when they started semaglutide or another blood sugar-lowering medication, or who became pregnant during the follow-up period
- People with a personal or family history of a specific type of thyroid cancer called medullary thyroid carcinoma
- People who are already taking part in another research study involving an experimental treatment or product
- People whose kidney function was severely reduced (measured by a specific blood test called eGFR being below 15 mL/min/1.73m²) at the study start date (confirm with trial site)
- People who used a GLP-1 medication other than semaglutide for more than 6 months after the study start date (applies to the Type 2 diabetes and obesity semaglutide groups)
- People who used another blood sugar-lowering medication for more than 6 months after the study start date within the first year of taking semaglutide (applies to the Type 2 diabetes and obesity semaglutide groups)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (416) 645-2929
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Change in HbA1c- 3 Years
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.